Brian Caveney

Track

Insider profile

Currently holds a position at Labcorp Holdings Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 47% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, President, Diagnostics and Chief Medical Officer Labcorp Holdings Inc Nov. 5, 2019 -
Senior Vice President, Chief Medical Officer Labcorp Holdings Inc Sept. 1, 2017 - Nov. 5, 2019
Brian Caveney's trades of Labcorp Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
286.77
Quantity 17,840 -20.2%
Value US$3,638,446
Transaction date
Proposed sale
Price
76.35
Quantity 15,555
Value US$1,493,102
Transaction date
Sale
Price
316.02
Quantity 94,759 +2.7%
Value US$2,427,051
Transaction date
Proposed sale
Price
247.00
Quantity 2,000
Value US$494,000
Transaction date
Planned purchase
Price
231.20
Quantity 44 +0.3%
Value US$10,251
Transaction date
Purchase
Price
242.19
Quantity 42 +0.3%
Value US$10,174
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-26 2026-02-24
S Sale
17,840 -20.2%
286.77
US$3,638,446 		17,840 -20.2% 286.77 US$3,638,446
2026-02-24 2026-02-24
PrS Proposed sale
15,555
76.35
US$1,493,102 		15,555 76.35 US$1,493,102
2025-06-05 2025-06-03
S Sale
94,759 +2.7%
316.02
US$2,427,051 		94,759 +2.7% 316.02 US$2,427,051
2025-06-03 2025-06-03
PrS Proposed sale
2,000
247.00
US$494,000 		2,000 247.00 US$494,000
2022-09-13 2022-09-07
PP Planned purchase
44 +0.3%
231.20
US$10,251 		44 +0.3% 231.20 US$10,251
2022-06-14 2022-06-07
B Purchase
42 +0.3%
242.19
US$10,174 		42 +0.3% 242.19 US$10,174